Add-On tolterodine extended release improves overactive bladder symptoms in men receiving alpha-blocker therapy

被引：0
|
作者：
Chapple, C. [1 ]
Abrams, P. [2 ]
Herschorn, S. [3 ]
Sun, F. [4 ]
Brodsky, M. [5 ]
Guan, Z. [5 ]
机构：
[1] Royal Hallamshire Hosp, Dept Urol, Sheffield S10 2JF, S Yorkshire, England
[2] Bristol Urol Inst, Dept Urol, Bristol, Avon, England
[3] Univ Toronto, Dept Urol, Toronto, ON, Canada
[4] Pfizer Inc, Dept Stat, New York, NY USA
[5] Pfizer Inc, Dept Med Urol, New York, NY USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2008年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
671
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
  • [1] Add-on tolterodine extended release improves overactive bladder symptoms in men receiving α-blocker therapy
    Herschorn, Sender
    Abrams, Paul
    Chapple, Christopher R.
    Sun, Franklin
    Brodsky, Marina
    Guan, Zhonghong
    JOURNAL OF UROLOGY, 2008, 179 (04): : 443 - 443
  • [2] Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia
    Kaplan, Steven A.
    Roehrborn, Claus G.
    Dmochowski, Roger
    Rovner, Eric S.
    Wang, Joseph T.
    Guan, Zhonghong
    UROLOGY, 2006, 68 (02) : 328 - 332
  • [3] Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving a-blocker treatment for lower urinary tract symptoms
    Kaplan, Steven A.
    Roehrborn, Claus G.
    Gong, Jason
    Sun, Franklin
    Guan, Zhonghong
    BJU INTERNATIONAL, 2012, 109 (12) : 1831 - 1840
  • [4] Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms
    Herschorn, Sender
    Heesakkers, John
    Castro-Diaz, David
    Wang, Joseph T.
    Brodsky, Marina
    Guan, Zhonghong
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3513 - 3521
  • [5] Meta-Analysis of the Efficacy and Safety of Imidafenacin for Overactive Bladder Induced by Benign Prostatic Hyperplasia in Men Receiving Alpha-Blocker Therapy
    Cai, Tong
    Wang, Ning
    Liang, Liye
    Zhou, Zhongbao
    Zhang, Yong
    Cui, Yuanshan
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2020, 24 (04) : 365 - 374
  • [6] Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration
    Chapple, Christopher R.
    Herschorn, Sender
    Abrams, Paul
    Wang, Joseph T.
    Brodsky, Marina
    Guan, Zhonghong
    BJU INTERNATIONAL, 2010, 106 (09) : 1332 - 1338
  • [7] TOLTERODINE EXTENDED RELEASE IMPROVES OVERACTIVE BLADDER SYMPTOMS IN MEN TREATED WITH α-BLOCKERS IRRESPECTIVE OF BASELINE SERUM PROSTATE-SPECIFIC ANTIGEN LEVEL
    Chapple, C. R.
    Herschorn, S.
    Abrams, P.
    Wang, J. T.
    Brodsky, M.
    Guan, Z.
    Al-Gamal, S. A.
    Ragab, M.
    Abo, Farha O. M.
    Taha, M. R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 166 - 166
  • [8] Effects of tolterodine extended release and/or tamsulosin on bladder diary variables in men with lower urinary tract symptoms including overactive bladder
    Kaplan, Steven A.
    Rovner, Eric S.
    Sussman, David O.
    Kreder, Karl
    Carlsson, Martin
    Bavendam, Tamara
    Guan, Zhonghong
    JOURNAL OF UROLOGY, 2007, 177 (04): : 512 - 513
  • [9] Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers
    Chapple, Christopher
    Herschorn, Sender
    Abrams, Paul
    Sun, Franklin
    Brodsky, Marina
    Guan, Zhonghong
    EUROPEAN UROLOGY, 2009, 56 (03) : 534 - 541
  • [10] Efficacy of tolterodine extended release for overactive bladder symptoms in sexually active postmenopausal women
    Bachmann, Gloria
    Wang, Joseph T.
    Morrow, Jon D.
    Bavendam, Tamara
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1082 - 1082
12345